Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells

Journal of Immunological Methods

Volumn 340, Issue 1, 2009, Pages 42-47

  Kyu, Shuya Y ^a   Kobie, James ^b,d   Yang, Hongmei ^e   Zand, Martin S ^c   Topham, David J ^d   Quataert, Sally A ^d   Sanz, Ignacio ^b   Lee, F Eun Hyung ^a  

^a Depts of Medicine and Physiology   (United States)

^b Division of Allergy   (United States)

^c Division of Nephrology   (United States)

^d Center for Vaccine Biology   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antibody secreting cells; Influenza; Plasmablasts; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; INFLUENZA VACCINE; VIRUS HEMAGGLUTININ;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; INFLUENZA VIRUS; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PRIORITY JOURNAL; STEM CELL; VACCINATION;

ADULT; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; MALE; YOUNG ADULT;

EID: 57249095757     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.09.025     Document Type: Article

References (7)

1. Amanna I.J., Carlson N.E., and Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357 (2007) 1903
2. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199
3. Cox R.J., Brokstad K.A., Zuckerman M.A., Wood J.M., Haaheim L.R., and Oxford J.S. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 12 (1994) 993
4. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dorner T., and Hiepe F. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 6 (2006) 741
5. Sasaki S., Jaimes M.C., Holmes T.H., Dekker C.L., Mahmood K., Kemble G.W., Arvin A.M., and Greenberg H.B. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J. Virol. 81 (2007) 215
6. Slifka M.K., and Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 10 (1998) 252
7. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.-Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., and Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453 (2008) 667